Table 2.
National Cancer Institute Common Toxicity Criteria for Adverse Events Grade 3 and 4 treatment-related adverse events in the phase ii study population (n=19)
Number of patients |
No. of events by grade |
|||
---|---|---|---|---|
Adverse event | No. | % | Grade 3 | Grade 4 |
Neutropenia | 9 | 47 | 7 | 2 |
Anemia | 2 | 11 | 2 | 0 |
Lymphopenia | 9 | 47 | 8 | 1 |
Leucopenia | 2 | 11 | 1 | 1 |
Hyperuricemia | 1 | 5 | 0 | 1 |
Hypokalemia | 1 | 5 | 1 | 0 |
Vomiting | 1 | 5 | 1 | 0 |
Upper respiratory infection | 1 | 5 | 1 | 0 |
Vascular access complication | 2 | 10 | 2 | 0 |